These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23764922)

  • 1. Elixirs of death. International organizations are working towards a global solution to address the problem of falsified and substandard medicines, but progress has stagnated.
    Weigmann K
    EMBO Rep; 2013 Jul; 14(7):597-600. PubMed ID: 23764922
    [No Abstract]   [Full Text] [Related]  

  • 2. How to achieve international action on falsified and substandard medicines.
    Attaran A; Barry D; Basheer S; Bate R; Benton D; Chauvin J; Garrett L; Kickbusch I; Kohler JC; Midha K; Newton PN; Nishtar S; Orhii P; McKee M
    BMJ; 2012 Nov; 345():e7381. PubMed ID: 23149211
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fake drugs, what are we talking about? Counterfeit drugs, informal market, quality of pharmaceutical… Thought from an anthropological study led in Benin].
    Baxerres C
    Bull Soc Pathol Exot; 2014 May; 107(2):121-6. PubMed ID: 24639135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When falsified medicines enter the supply chain: description of an incident in Kenya and lessons learned for rapid response.
    Cohn J; von Schoen-Angerer T; Jambert E; Arreghini G; Childs M
    J Public Health Policy; 2013 Jan; 34(1):22-30. PubMed ID: 23172047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of substandard and falsified antimalarials in Zambia: application of the SAFARI model.
    Jackson KD; Higgins CR; Laing SK; Mwila C; Kobayashi T; Ippolito MM; Sylvia S; Ozawa S
    BMC Public Health; 2020 Jul; 20(1):1083. PubMed ID: 32646393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory framework for access to safe, effective quality medicines.
    Rägo L; Sillo H; 't Hoen E; Zweygarth M
    Antivir Ther; 2014; 19 Suppl 3():69-77. PubMed ID: 25310085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Counterfeit medicines. Bitter pills.
    Jack A
    BMJ; 2007 Dec; 335(7630):1120-1. PubMed ID: 18048535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European union has the falsified medicines directive.
    Taaffe T
    BMJ; 2012 Dec; 345():e8356. PubMed ID: 23256949
    [No Abstract]   [Full Text] [Related]  

  • 9. Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.
    Petersen A; Held N; Heide L;
    PLoS One; 2017; 12(9):e0184165. PubMed ID: 28877208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commentary: Substandard medicines are the priority for neglected tropical diseases.
    Dorlo TP; Ravinetto RM; Beijnen JH; Boelaert M
    BMJ; 2012 Nov; 345():e7518. PubMed ID: 23152570
    [No Abstract]   [Full Text] [Related]  

  • 11. [The Herceptin® case : A case of falsification of medicinal products to a greater extent].
    Streit R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1203-1207. PubMed ID: 28936679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The FDA Safety and Innovation Act.
    Steinbrook R; Sharfstein JM
    JAMA; 2012 Oct; 308(14):1437-8. PubMed ID: 23047356
    [No Abstract]   [Full Text] [Related]  

  • 13. [Counterfeit and Falsified Drugs: an Overview].
    Taverriti-Fortier C; Pape E; Scala-Bertola J; Tréchot P; Maincent P; Gibaja V; Gambier N
    Therapie; 2015; 70(5):455-64. PubMed ID: 26071144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combatting substandard and falsified medicines: a view from Rwanda.
    Binagwaho A; Bate R; Gasana M; Karema C; Mucyo Y; Mwesigye JP; Biziyaremye F; Nutt CT; Wagner CM; Jensen P; Attaran A
    PLoS Med; 2013; 10(7):e1001476. PubMed ID: 23843747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Falsified antimalarials: a minireview.
    Chaccour C; Kaur H; Del Pozo JL
    Expert Rev Anti Infect Ther; 2015 Apr; 13(4):505-9. PubMed ID: 25683870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.
    Ozawa S; Evans DR; Bessias S; Haynie DG; Yemeke TT; Laing SK; Herrington JE
    JAMA Netw Open; 2018 Aug; 1(4):e181662. PubMed ID: 30646106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defeat of antipiracy treaty is hailed as victory for generic drugs.
    Moszynski P
    BMJ; 2012 Jul; 345():e4660. PubMed ID: 22777031
    [No Abstract]   [Full Text] [Related]  

  • 18. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global perspective of the risks of falsified and counterfeit medicines: A critical review of the literature.
    Feeney AJ; Goad JA; Flaherty GT
    Travel Med Infect Dis; 2024; 61():102758. PubMed ID: 39218049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticounterfeiting agreement will hinder trade in generic drugs, protesters say.
    Limb M
    BMJ; 2012 Jun; 344():e4073. PubMed ID: 22689897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.